ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
ImmuCell Corporation ICCC has received a recommendation upgrade to “Outperform,” driven by consistent execution across its sales and gross margin profile, alongside emerging strategic optionality linked to its late-stage mastitis treatment, Re-Tain. The company’s operational rebound, product mix strength and capacity scaling provide a solid base …